463 related articles for article (PubMed ID: 35087589)
1. Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.
Mortazavi D; Sohrabi B; Mosallaei M; Nariman-Saleh-Fam Z; Bastami M; Mansoori Y; Daraei A; Zununi Vahed S; Navid S; Saadatian Z; Jamialahmadi T; Teng Y; Sahebkar A
J Oncol; 2022; 2022():4889807. PubMed ID: 35087589
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Regulation of p21
Ocker M; Bitar SA; Monteiro AC; Gali-Muhtasib H; Schneider-Stock R
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31514410
[TBL] [Abstract][Full Text] [Related]
3. Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.
Karimzadeh MR; Pourdavoud P; Ehtesham N; Qadbeigi M; Asl MM; Alani B; Mosallaei M; Pakzad B
Cancer Gene Ther; 2021 Apr; 28(3-4):157-174. PubMed ID: 32773776
[TBL] [Abstract][Full Text] [Related]
4. Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities.
De Marco K; Sanese P; Simone C; Grossi V
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894343
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs and Epigenetics.
Moutinho C; Esteller M
Adv Cancer Res; 2017; 135():189-220. PubMed ID: 28882223
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics.
Sundar IK; Mullapudi N; Yao H; Spivack SD; Rahman I
Curr Opin Pulm Med; 2011 Jul; 17(4):279-85. PubMed ID: 21537190
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic deregulation of microRNAs: new opportunities to target oncogenic signaling pathways in hepatocellular carcinoma.
Yu Z; Cheng AS
Curr Pharm Des; 2013; 19(7):1192-200. PubMed ID: 23092339
[TBL] [Abstract][Full Text] [Related]
8. Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis.
Kim HS; Shen Q; Nam SW
J Korean Med Sci; 2015 Oct; 30(10):1375-80. PubMed ID: 26425032
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Regulation of Skeletal Tissue Integrity and Osteoporosis Development.
Chen YS; Lian WS; Kuo CW; Ke HJ; Wang SY; Kuo PC; Jahr H; Wang FS
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664681
[TBL] [Abstract][Full Text] [Related]
10. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
Sankrityayan H; Kulkarni YA; Gaikwad AB
Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
[TBL] [Abstract][Full Text] [Related]
11. miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.
Amodio N; Rossi M; Raimondi L; Pitari MR; Botta C; Tagliaferri P; Tassone P
Oncotarget; 2015 May; 6(15):12837-61. PubMed ID: 25968566
[TBL] [Abstract][Full Text] [Related]
12. Regulation of microRNAs by epigenetics and their interplay involved in cancer.
Liu X; Chen X; Yu X; Tao Y; Bode AM; Dong Z; Cao Y
J Exp Clin Cancer Res; 2013 Nov; 32(1):96. PubMed ID: 24261995
[TBL] [Abstract][Full Text] [Related]
13. Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs.
Zhang X; Hou J; Lu M
Front Genet; 2013 Oct; 4():202. PubMed ID: 24133502
[TBL] [Abstract][Full Text] [Related]
14. A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.
Sheervalilou R; Shirvaliloo S; Fekri Aval S; Khamaneh AM; Sharifi A; Ansarin K; Zarghami N
Tumour Biol; 2017 May; 39(5):1010428317695032. PubMed ID: 28468581
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of miRNAs in cancer.
Fabbri M; Calore F; Paone A; Galli R; Calin GA
Adv Exp Med Biol; 2013; 754():137-48. PubMed ID: 22956499
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic activation of tumor suppressor microRNAs in human cancer cells.
Saito Y; Jones PA
Cell Cycle; 2006 Oct; 5(19):2220-2. PubMed ID: 17012846
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer.
Sundar IK; Rahman I
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1245-L1258. PubMed ID: 27793800
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
Mekala JR; Naushad SM; Ponnusamy L; Arivazhagan G; Sakthiprasad V; Pal-Bhadra M
Gene; 2018 Jan; 641():248-258. PubMed ID: 29038000
[TBL] [Abstract][Full Text] [Related]
19. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
Mai A; Altucci L
Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
[TBL] [Abstract][Full Text] [Related]
20. Histone lysine demethylases in Drosophila melanogaster.
Holowatyj A; Yang ZQ; Pile LA
Fly (Austin); 2015; 9(1):36-44. PubMed ID: 26207949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
